Individual Prediction in Prostate Cancer Studies Using a Joint Longitudinal Survival–Cure Model

From MaRDI portal
Publication:3632627

DOI10.1198/016214507000000400zbMath1469.62383OpenAlexW2030118009MaRDI QIDQ3632627

Menggang Yu, Howard M. Sandler

Publication date: 12 June 2009

Published in: Journal of the American Statistical Association (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1198/016214507000000400




Related Items (14)

A characterization of missingness at random in a generalized shared-parameter joint modeling framework for longitudinal and time-to-event data, and sensitivity analysisJoint analysis of longitudinal data and competing terminal events in the presence of dependent observation times with application to chronic kidney diseaseJoint modeling of longitudinal proportional measurements and survival time with a cure fractionIdentifiability of cure models revisitedReal‐Time Individual Predictions of Prostate Cancer Recurrence Using Joint ModelsA Bayesian Semiparametric Survival Model with Longitudinal MarkersA continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinomaAssessing the association between trends in a biomarker and risk of event with an application in pediatric HIV/AIDSJoint models for longitudinal counts and left-truncated time-to event data with applications to health insuranceDiscussion of: ``Predictive comparison of joint longitudinal-survival modeling: a case study illustrating competing approachesA joint survival-longitudinal modelling approach for the dynamic prediction of rehospitalization in telemonitored chronic heart failure patientsDynamic Predictions and Prospective Accuracy in Joint Models for Longitudinal and Time-to-Event DataJoint modeling of longitudinal and cure-survival dataA new approach for joint modelling of longitudinal measurements and survival times with a cure fraction






This page was built for publication: Individual Prediction in Prostate Cancer Studies Using a Joint Longitudinal Survival–Cure Model